Comparison of Serum Hepatitis B Virus RNA Levels and Quasispecies Evolution Patterns between Entecavir and Pegylated-Interferon Mono-treatment in Chronic Hepatitis B Patients

por Yu, Xiao-qi, Wang, Ming-jie, Yu, De-min, Chen, Pei-zhan, Zhu, Ming-yu, Huang, Wei, Han, Yue, Gong, Qi-ming, Zhang, Xin-xin
Publicado 2020

Characteristics of CpG Islands and their quasispecies of full-length hepatitis B virus genomes from patients at different phases of infection

por Xue, Yuan, Wang, Ming-Jie, Huang, Su-Yuan, Yang, Zhi-Tao, Yu, De-Min, Han, Yue, Zhu, Ming-Yu, Huang, Dao, Zhang, Dong-Hua, Gong, Qi-Ming, Zhang, Xin-Xin
Publicado 2016

Clinical and molecular characterization of Wilson's disease in China: identification of 14 novel mutations

por Li, Xin-Hua, Lu, Yi, Ling, Yun, Fu, Qing-Chun, Xu, Jie, Zang, Guo-Qing, Zhou, Feng, De-Min, Yu, Han, Yue, Zhang, Dong-Hua, Gong, Qi-Ming, Lu, Zhi-Meng, Kong, Xiao-Fei, Wang, Jian-She, Zhang, Xin-Xin
Publicado 2011

Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon‐α treatment in HBeAg‐positive chronic hepatitis B patients

por Zhu, Ming‐Yu, Chen, Pei‐Zhan, Li, Jing, Yu, De‐Min, Huang, Dao, Zhu, Xue‐Juan, Han, Yue, Chen, Jie, Huang, Wei, Chen, Yong‐Yan, Gong, Qi‐Ming, Jiang, Jie‐Hong, Zhang, Dong‐Hua, Zhang, Yan, Zhang, Ji‐Ming, Zhang, Xin‐Xin
Publicado 2018